日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer

利用多组学技术解析卵巢癌的复杂性

Lin, Shijuan; Nguyen, Lily L; McMellen, Alexandra; Leibowitz, Michael S; Davidson, Natalie; Spinosa, Daniel; Bitler, Benjamin G

SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

SM08502 介导的 β-catenin 抑制与奥拉帕尼协同作用抑制肿瘤进展。

Corr Bradley R, Woodruff Elizabeth R, Yamamoto Tomomi M, Jordan Kimberly R, Danhorn Thomas, Bossard Carine, Nguyen Lily L, Chuong Edward B, Wick Lars, Young Alexandra, Kusumoto Shinya, Orsulic Sandra, Barroilhet Lisa, Bitler Benjamin G

Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.

结合 EHMT 和 PARP 抑制:一种在抑制耐药性卵巢癌肿瘤生长的同时刺激免疫激活的策略

Nguyen Lily L, Watson Zachary L, Ortega Raquel, Woodruff Elizabeth R, Jordan Kimberly R, Iwanaga Ritsuko, Yamamoto Tomomi M, Bailey Courtney A, To Francis, Jeong Abigail D, Guntupalli Saketh R, Behbakht Kian, Gibaja Veronica, Arnoult Nausica, Cocozaki Alexis, Chuong Edward B, Bitler Benjamin G

EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

EHMT1/2 抑制以 CD8 T 细胞依赖的方式促进耐药性卵巢癌肿瘤的消退

Nguyen Lily L, Watson Zachary L, Ortega Raquel, Woodruff Elizabeth R, Jordan Kimberly R, Iwanaga Ritsuko, Yamamoto Tomomi M, Bailey Courtney A, To Francis, Lin Shujian, Villagomez Fabian R, Jeong Abigail D, Guntupalli Saketh R, Behbakht Kian, Gibaja Veronica, Arnoult Nausica, Chuong Edward B, Bitler Benjamin G